Michael Seth Altman's Net Worth
$8.91 Million
Who is Michael Seth Altman?
Michael Seth Altman has an estimated net worth of $8.91 Million. This is based on reported shares across multiple companies, which include Nautilus Biotechnology, Inc., ARYA Sciences Acquisition Corp IV, ARYA Sciences Acquisition Corp V, ARYA Sciences Acquisition Corp II, Lyra Therapeutics, Inc., and ARYA SCIENCES ACQUISITION CORP..
SEC CIK
Michael Seth Altman's CIK is 0001746738
Past Insider Trading and Trends
2021 was Michael Seth Altman's most active year for acquiring shares with 6 total transactions. Michael Seth Altman's most active month to acquire stocks was the month of May. 2021 was Michael Seth Altman's most active year for disposing of shares, totalling 2 transactions. Michael Seth Altman's most active month to dispose stocks was the month of May. 2021 saw Michael Seth Altman paying a total of $9,980,000.00 for 5,196,185 shares, this is the most they've acquired in one year. In 2021 Michael Seth Altman cashed out on 4,146,500 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nautilus Biotechnology, Inc. (NAUT) Snapshot price: $2.67
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| +730.96% | 3.65M |
—
|
—
| 4.15M |
Jun 9
| |||
Form 4
|
∞
| 499K |
$10.00 | $4,990,000.00 | 499K |
Aug 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARYA Sciences Acquisition Corp IV (ARYD) Snapshot price: $10.85
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 499K |
$10.00 | $4,990,000.00 | 499K |
Mar 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARYA Sciences Acquisition Corp V No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 499K |
$10.00 | $4,990,000.00 | 499K |
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARYA Sciences Acquisition Corp II (CERE) Snapshot price: $41.66
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 499K |
$10.00 | $4,990,000.00 | 499K |
Jun 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lyra Therapeutics, Inc. (LYRA) Snapshot price: $4.89
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||